Surgical factors influencing outcomes in patients resected for cancer of the esophagus or gastric cardia.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 18716831)

Published in World J Surg on November 01, 2008

Authors

Martin Sundelöf1, Jesper Lagergren, Weimin Ye

Author Affiliations

1: Department of Surgery, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden. martin.sundelof@ds.se

Articles cited by this

Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79

Surgeon volume and operative mortality in the United States. N Engl J Med (2003) 16.97

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol (2005) 5.40

Hospital volume and operative mortality in cancer surgery: a national study. Arch Surg (2003) 3.21

Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg (2000) 2.86

Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg (2001) 2.49

Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Comparison of three-field lymphadenectomy with two-field lymphadenectomy. Ann Surg (1995) 2.27

Treatment outcomes of resected esophageal cancer. Ann Surg (2002) 2.03

Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer (2005) 1.99

Postoperative mortality following oesophagectomy and problems in reporting its rate. Br J Surg (2004) 1.76

Adenocarcinoma of the esophagus and cardia: a review of the disease and its treatment. Ann Surg Oncol (2006) 1.71

En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg (1997) 1.61

Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol (2005) 1.53

Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys (2005) 1.46

Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg (2006) 1.44

Impact of hospital volume on long-term survival after esophageal cancer surgery. Arch Surg (2007) 1.38

Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol (2005) 1.34

Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg (2006) 1.24

Prognostic factors of resected adenocarcinoma of the esophagus. Surgery (1995) 1.24

Improved prognosis of resected esophageal cancer. World J Surg (2004) 1.14

Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer (2002) 1.08

Improving outcomes after esophagectomy: the impact of operative volume. J Surg Oncol (2005) 1.08

Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomy. World J Surg (2003) 1.03

Lymphatic vessel invasion is an independent prognostic factor in patients with a primary resected tumor with esophageal squamous cell carcinoma. Cancer (2001) 0.98

Comparison of the clinical and histological characteristics and survival of distal esophageal-gastroesophageal junction adenocarcinoma in patients with and without barrett mucosa. Arch Surg (2005) 0.94

High-volume centers--effect of case load on outcome in cancer surgery. Onkologie (2004) 0.90

The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia. Anticancer Res (2005) 0.87

Mortality and morbidity after esophagogastrectomy for cancer of the esophagus and cardia. Am Surg (1977) 0.85

Articles by these authors

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer (2009) 4.50

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. Gut (2013) 4.29

Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84

Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med (2012) 3.56

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer (2006) 3.38

Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Ann Intern Med (2003) 3.30

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77

Trends in incidence and mortality of nasopharyngeal carcinoma over a 20-25 year period (1978/1983-2002) in Sihui and Cangwu counties in southern China. BMC Cancer (2006) 2.71

Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol (2006) 2.65

Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63

Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2010) 2.47

Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction. J Clin Oncol (2014) 2.41

Reproducibility and validity of major dietary patterns among Swedish women assessed with a food-frequency questionnaire. J Nutr (2004) 2.39

Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a prospective cohort study. Gastrointest Endosc (2010) 2.28

Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol (2007) 2.27

Increased risk of colorectal cancer after obesity surgery. Ann Surg (2013) 2.17

Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial. BMJ (2010) 2.11

Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. J Natl Cancer Inst (2005) 2.03

Smokeless tobacco and the risk of stroke. Epidemiology (2008) 1.89

Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol (2009) 1.87

Familial aggregation of amyotrophic lateral sclerosis. Ann Neurol (2009) 1.86

Low risk of gastrointestinal cancer among patients with celiac disease, inflammation, or latent celiac disease. Clin Gastroenterol Hepatol (2011) 1.85

Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol (2007) 1.80

Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control (2005) 1.80

Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst (2003) 1.79

Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology (2002) 1.76

Phylogenetic Relationships and Genetic Variation in Longidorus and Xiphinema Species (Nematoda: Longidoridae) Using ITS1 Sequences of Nuclear Ribosomal DNA. J Nematol (2004) 1.74

A population-based study showing an association between gastroesophageal reflux disease and sleep problems. Clin Gastroenterol Hepatol (2009) 1.71

A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet (2013) 1.67

Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst (2010) 1.60

Quality of life and persisting symptoms after oesophageal cancer surgery. Eur J Cancer (2006) 1.59

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52

Head injury and Parkinson's disease: a population-based study. Mov Disord (2012) 1.52

The risk of esophageal adenocarcinoma after antireflux surgery. Gastroenterology (2010) 1.50

Risk of obesity-related cancer after obesity surgery in a population-based cohort study. Ann Surg (2010) 1.50

The incidence of tonsillar cancer in Sweden is increasing. Acta Otolaryngol (2007) 1.49

Complications after percutaneous endoscopic gastrostomy in a prospective study. Scand J Gastroenterol (2012) 1.49

Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer (2008) 1.48

Weight loss and reduction in gastroesophageal reflux. A prospective population-based cohort study: the HUNT study. Am J Gastroenterol (2013) 1.48

Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997. Eur J Epidemiol (2007) 1.45

Risk factors for esophageal adenocarcinoma after antireflux surgery. Ann Surg (2013) 1.44

Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol (2009) 1.44

Risk factors for complications after esophageal cancer resection: a prospective population-based study in Sweden. Ann Surg (2006) 1.44

Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study. Int J Cancer (2006) 1.40

[How resident physicians milestones for medical science are reached with high quality]. Lakartidningen (2013) 1.39

Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study. J Clin Oncol (2013) 1.39

Rationales, design and recruitment of the Taizhou Longitudinal Study. BMC Public Health (2009) 1.39

Impact of hospital volume on long-term survival after esophageal cancer surgery. Arch Surg (2007) 1.38

Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol (2005) 1.34

Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2006) 1.32

Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut (2012) 1.32

Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol (2012) 1.30

Description of Hemicaloosia graminis n. sp. (Nematoda: Caloosiidae) Associated with Turfgrasses in North and South Carolina, USA. J Nematol (2012) 1.30

Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008. Gut (2012) 1.29

Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study. Int J Cancer (2007) 1.27

Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Int J Cancer (2011) 1.26

Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: prospective cohort study. PLoS Med (2009) 1.26

Effects of physical activity, body mass index, waist-to-hip ratio and waist circumference on total mortality risk in the Swedish National March Cohort. Eur J Epidemiol (2010) 1.26

Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study. Ann Surg Oncol (2011) 1.25

Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst (2013) 1.25

Titration-free massively parallel pyrosequencing using trace amounts of starting material. Nucleic Acids Res (2010) 1.25

Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg (2006) 1.24

Eight-signature classifier for prediction of nasopharyngeal [corrected] carcinoma survival. J Clin Oncol (2011) 1.23

Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS One (2011) 1.22

Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study. Cancer Causes Control (2007) 1.22

Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden. Eur J Cancer (2008) 1.22

Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev (2004) 1.22

Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology (2006) 1.22

Workplace exposures and the risk of amyotrophic lateral sclerosis. Environ Health Perspect (2009) 1.21

Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden. Diabetes Care (2005) 1.20

Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut (2011) 1.18

Psychosocial working conditions and the risk of esophageal and gastric cardia cancers. Eur J Epidemiol (2004) 1.18

Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden. Nutr Cancer (2006) 1.15

A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control (2010) 1.14

Fruit and vegetable consumption and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer (2009) 1.14

Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev (2005) 1.14

Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes: a population-based cohort study in Sweden. Diabetes Care (2008) 1.12

Cancer risk among patients with condylomata acuminata. Int J Cancer (2006) 1.12

Longidorus kheirii n. sp. (Nematoda: Longidoridae) from Iran. Syst Parasitol (2008) 1.11

Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.11

Risk of esophageal adenocarcinoma in achalasia patients, a retrospective cohort study in Sweden. Am J Gastroenterol (2011) 1.10

Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer (2002) 1.08

Antibiotic exposure and the development of coeliac disease: a nationwide case-control study. BMC Gastroenterol (2013) 1.07

Risk of gastroesophageal cancer among smokers and users of Scandinavian moist snuff. Int J Cancer (2008) 1.07

The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis (2006) 1.07

Clinical management of obese patients with cancer. Nat Rev Clin Oncol (2013) 1.06

Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis--a prospective cohort study. Neuroepidemiology (2006) 1.06

Dietary intake of heterocyclic amines and cancers of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2003) 1.06

Increased population prevalence of reflux and obesity in the United Kingdom compared with Sweden: a potential explanation for the difference in incidence of esophageal adenocarcinoma. Eur J Gastroenterol Hepatol (2011) 1.06

Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut (2011) 1.05